Expanded Indications, Novel Targets Driving Activity In Autoimmune Disease Therapeutics

Already a major therapeutic disease sector accounting for drug sales in excess of $18 billion worldwide, the incidence of autoimmune disease in developed countries is increasing. The impact of autoimmunity on patient quality-of-life is well known, but it has only been in the last ten years with the introduction of biological drugs capable of modulating the immune cascade that effective therapies for this most intractable family of diseases have become available.

More: continued here

Filed under: Arthritis on October 27th, 2008